Stocky turns companies like Fresenius Medical Care AG into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. FMCQF trades at a reasonable 10.3× forward earnings but lacks the growth momentum (36/100 Growth Compounder Score) or margin resilience (47/100 Value Compounder Score) to justify conviction. Leadership alignment is middling (59/100), and the business carries only an adequate financial buffer against downturns, leaving limited room for error.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Fresenius Medical Care AG:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 50/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Fresenius Medical Care AG (FMCQF) at 50/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. FMCQF trades at a reasonable 10.3× forward earnings but lacks the growth momentum (36/100 Growth Compounder Score) or margin resilience (47/100 Value Compounder Score) to justify conviction. Leadership alignment is middling (59/10
FMCQF's current Stocky Verdict is 50/100, placing it in the "Cautious" band. This composite combines a 47/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Fresenius Medical Care AG yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Fresenius Medical Care AG scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Fresenius Medical Care AG's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Fresenius Medical Care AG.
Sign up free and unlock the full analysis on FMCQF — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for FMCQF in the app.
